INTRODUCTION: Adipose-derived stem cells (ADSCs) are a somatic stem cell population contained in fat tissue that possess the ability for self-renewal, differentiation into one or more phenotypes, and functional regeneration of damaged tissue, which may benefit the recovery of erectile function by using a stem cell-based therapy. AIM: To review available evidence concerning ADSCs availability, differentiation into functional cells, and the potential of these cells for the treatment of erectile dysfunction (ED). METHODS: We examined the current data (from 1964 to 2008) associated with the definition, characterization, differentiation, and application of ADSCs, as well as other kinds of stem cells for the cell-based therapies of ED. MAIN OUTCOME MEASURES: There is strong evidence supporting the concept that ADSCs may be a potential stem cell therapy source in treating ED. RESULTS: The ADSCs are paravascularly localized in the adipose tissue. Under specific induction medium conditions, these cells differentiated into neuron-like cells, smooth muscle cells, and endothelium in vitro. The insulin-like growth factor/insulin-like growth factor receptor (IGF/IGFR) pathway participates in neuronal differentiation while the fibroblast growth factor 2 (FGF2) pathway is involved in endothelium differentiation. In a preliminary in vivo experiment, the ADSCs functionally recovered the damaged erectile function. However, the underlying mechanism needs to be further examined. CONCLUSION: The ADSCs are a potential source for stem cell-based therapies, which imply the possibility of an effective clinical therapy for ED in the near future.
INTRODUCTION: Adipose-derived stem cells (ADSCs) are a somatic stem cell population contained in fat tissue that possess the ability for self-renewal, differentiation into one or more phenotypes, and functional regeneration of damaged tissue, which may benefit the recovery of erectile function by using a stem cell-based therapy. AIM: To review available evidence concerning ADSCs availability, differentiation into functional cells, and the potential of these cells for the treatment of erectile dysfunction (ED). METHODS: We examined the current data (from 1964 to 2008) associated with the definition, characterization, differentiation, and application of ADSCs, as well as other kinds of stem cells for the cell-based therapies of ED. MAIN OUTCOME MEASURES: There is strong evidence supporting the concept that ADSCs may be a potential stem cell therapy source in treating ED. RESULTS: The ADSCs are paravascularly localized in the adipose tissue. Under specific induction medium conditions, these cells differentiated into neuron-like cells, smooth muscle cells, and endothelium in vitro. The insulin-like growth factor/insulin-like growth factor receptor (IGF/IGFR) pathway participates in neuronal differentiation while the fibroblast growth factor 2 (FGF2) pathway is involved in endothelium differentiation. In a preliminary in vivo experiment, the ADSCs functionally recovered the damaged erectile function. However, the underlying mechanism needs to be further examined. CONCLUSION: The ADSCs are a potential source for stem cell-based therapies, which imply the possibility of an effective clinical therapy for ED in the near future.
Authors: Gregory S Jack; Fernando G Almeida; Rong Zhang; Zeni C Alfonso; Patricia A Zuk; Larissa V Rodríguez Journal: J Urol Date: 2005-11 Impact factor: 7.450
Authors: I G Gonzalez-Herrera; L Prado-Lourenco; S Teshima-Kondo; K Kondo; F Cabon; J-F Arnal; F Bayard; A-C Prats Journal: Biochem Soc Trans Date: 2006-02 Impact factor: 5.407
Authors: Stefan Lendeckel; Andreas Jödicke; Petros Christophis; Kathrin Heidinger; Jan Wolff; John K Fraser; Marc H Hedrick; Lars Berthold; Hans-Peter Howaldt Journal: J Craniomaxillofac Surg Date: 2004-12 Impact factor: 2.078
Authors: Weiwen Deng; Trinity J Bivalacqua; Natasha N Chattergoon; Albert L Hyman; James R Jeter; Philip J Kadowitz Journal: Am J Physiol Cell Physiol Date: 2003-07-23 Impact factor: 4.249
Authors: Seung Hwan Lee; In Gul Kim; Ae Ryang Jung; Kshitiz Raj Shrestha; Jin Ho Lee; Ki Dong Park; Byung Ha Chung; Sae Woong Kim; Ki Hean Kim; Ji Youl Lee Journal: Tissue Eng Part A Date: 2014-05-20 Impact factor: 3.845
Authors: Dalsan You; Myoung Jin Jang; Bo Hyun Kim; Geehyun Song; Chunwoo Lee; Nayoung Suh; In Gab Jeong; Tai Young Ahn; Choung-Soo Kim Journal: Stem Cells Transl Med Date: 2015-04 Impact factor: 6.940
Authors: Faysal A Yafi; Lawrence Jenkins; Maarten Albersen; Giovanni Corona; Andrea M Isidori; Shari Goldfarb; Mario Maggi; Christian J Nelson; Sharon Parish; Andrea Salonia; Ronny Tan; John P Mulhall; Wayne J G Hellstrom Journal: Nat Rev Dis Primers Date: 2016-02-04 Impact factor: 52.329